FDA approves CRM monitoring system

The FDA approved Smartview technology to remotely monitor patients with implanted cardiac rhythm management (CRM) devices. The system allows patients to transmit data electronically from implanted cardiac devices to their physicians.

The system uses Smartview and Paradym RF devices, according to manufacturer Sorin Group, which initiated its U.S. launch of the Paradym RF VR and DR implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) devices in May 2012.

The Milan, Italy-based company said it was now beginning its launch of Smartview in the U.S.

Candace Stuart, Contributor

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup